U.S. Department of Health & Human Services Divider Arrow National Institutes of Health Divider Arrow NCATS

Details

Stereochemistry ABSOLUTE
Molecular Formula C19H24O2
Molecular Weight 284.3927
Optical Activity UNSPECIFIED
Defined Stereocenters 5 / 5
E/Z Centers 0
Charge 0

SHOW SMILES / InChI
Structure of BOLDIONE

SMILES

C[C@]12CC[C@H]3[C@@H](CCC4=CC(=O)C=C[C@]34C)[C@@H]1CCC2=O

InChI

InChIKey=LUJVUUWNAPIQQI-QAGGRKNESA-N
InChI=1S/C19H24O2/c1-18-9-7-13(20)11-12(18)3-4-14-15-5-6-17(21)19(15,2)10-8-16(14)18/h7,9,11,14-16H,3-6,8,10H2,1-2H3/t14-,15-,16-,18-,19-/m0/s1

HIDE SMILES / InChI

Molecular Formula C19H24O2
Molecular Weight 284.3927
Charge 0
Count
Stereochemistry ABSOLUTE
Additional Stereochemistry No
Defined Stereocenters 5 / 5
E/Z Centers 0
Optical Activity UNSPECIFIED

Boldione, also known as androstadienedione or 1-dehydroandrostenedione, as well as 1,4-androstadiene-3,17-dione, is an important industrial precursor for various steroid hormones. Boldione is a direct precursor (prohormone) to the anabolic steroid boldenone (1,4-androstadiene-17beta-ol-3-one). It is advertised as a highly anabolic/androgenic compound promoting muscularity, enhancing strength and overall physical performance, and is available on the Internet and in health stores. Boldione was marketed as a prohormone “dietary supplement” for many years in the mid-2000’s, but it is truly a potent precursor (ie. converts in the body) to the anabolic steroid Boldenone. In 2005 the Anabolic Steroid Control Act of 2005 classified boldenone as a Schedule III controlled illegal steroid.

Approval Year

Targets

Targets

Primary TargetPharmacologyConditionPotency
120.0 nM [Ki]
Conditions

Conditions

ConditionModalityTargetsHighest PhaseProduct
PubMed

PubMed

TitleDatePubMed
Primary hepatocytes as an useful bioassay to characterize metabolism and bioactivity of illicit steroids in cattle.
2012-10
A new steroid-transforming strain of Mycobacterium neoaurum and cloning of 3-ketosteroid 9alpha-hydroxylase in NwIB-01.
2010-11
Testosterone metabolism revisited: discovery of new metabolites.
2010-10
Degradation kinetics of testosterone by manure-borne bacteria: influence of temperature, pH, glucose amendments, and dissolved oxygen.
2010-09-14
Quantification of testosterone and metabolites released after alkaline treatment in human urine.
2010-07-09
Initial steps in anoxic testosterone degradation by Steroidobacter denitrificans.
2010-07
Characterisation of steroids in wooden crates of veal calves by accelerated solvent extraction (ASE) and ultra-high performance liquid chromatography coupled to triple quadrupole mass spectrometry (U-HPLC-QqQ-MS-MS).
2010-05
Cholesterol utilization in mycobacteria is controlled by two TetR-type transcriptional regulators: kstR and kstR2.
2010-05
Cholesterol biotransformation to androsta-1,4-diene-3,17-dione by growing cells of Chryseobacterium gleum.
2010-05
Investigation on possible transformations of cortisol, cortisone and cortisol glucuronide in bovine faecal matter using liquid chromatography-mass spectrometry.
2010-04
Probing the binding pocket of the active site of aromatase with 2-phenylaliphatic androsta-1,4-diene-3,17-dione steroids.
2010-04
Simultaneous determination of 15 steroids in rat blood via gas chromatography-mass spectrometry to evaluate the impact of emasculation on adrenal.
2009-12-15
Classification of three steroids as schedule III anabolic steroids under the Controlled Substances Act. Final rule.
2009-12-04
Cholesterol oxidase: physiological functions.
2009-12
Excretion of endogenous boldione in human urine: influence of phytosterol consumption.
2009-10
Criteria to distinguish between natural situations and illegal use of boldenone, boldenone esters and boldione in cattle 2. Direct measurement of 17beta-boldenone sulpho-conjugate in calf urine by liquid chromatography--high resolution and tandem mass spectrometry.
2009-10
Aromatase inactivation by 2-substituted derivatives of the suicide substrate androsta-1,4-diene-3,17-dione.
2009-09
Sitosterol bioconversion with resting cells in liquid polymer based systems.
2009-09
Characterization of 3-ketosteroid 9{alpha}-hydroxylase, a Rieske oxygenase in the cholesterol degradation pathway of Mycobacterium tuberculosis.
2009-04-10
A new mixed micellar electrokinetic chromatography method for analysis of natural and synthetic anabolic steroids.
2009-01-15
Fractionation of free and conjugated steroids for the detection of boldenone metabolites in calf urine with ultra-performance liquid chromatography/tandem mass spectrometry.
2008-08
Boldenone, testosterone and 1,4-androstadiene-3,17-dione determination in faeces from horses, untreated and after administration of androsta-1,4-diene-3,17-dione (boldione).
2008-06
Naturally occurring progesterone in loblolly pine (Pinus taeda L.): a major steroid precursor of environmental androgens.
2008-06
Comprehensive screening of acidic and neutral drugs in equine plasma by liquid chromatography-tandem mass spectrometry.
2008-05-02
Enhancement of androstadienedione production from progesterone by biotransformation using the hydroxypropyl-beta-cyclodextrin complexation technique.
2008-01
Evaluation of boldenone formation and related steroids transformations in veal faeces by liquid chromatography/tandem mass spectrometry.
2008
Pathology of the testicle and sex accessory glands following the administration of boldenone and boldione as growth promoters in veal calves.
2007-11
Boldenone, boldione, and milk replacers in the diet of veal calves: the effects of phytosterol content on the urinary excretion of boldenone metabolites.
2007-10-03
Development of a rapid normal-phase LC-positive ion APCI-MS method for simultaneous detection and quantitation of cholesterol, androst-4-ene-3,1 7-dione, and androsta-1,4-diene-3,17-dione.
2007-09
Integrated analytical approach in veal calves administered the anabolic androgenic steroids boldenone and boldione: urine and plasma kinetic profile and changes in plasma protein expression.
2007-09
[Preparation of androsta-1,4-diene-3,17-dione from sterols using Mycobacterium neoaurum VKPM As-1656 strain].
2007-08-09
Methyl-beta-cyclodextrin alters growth, activity and cell envelope features of sterol-transforming mycobacteria.
2007-06
Excretion profile of boldenone and its metabolites after oral administration to veal calves.
2007-04-25
An in vitro study on metabolism of 17beta-boldenone and boldione using cattle liver and kidney subcellular fractions.
2007-03-14
Formation of boldenone and boldenone-analogues by maggots of Lucilia sericata.
2007-03-14
Development and validation of a liquid chromatography-tandem mass spectrometry method for the separation of conjugated and unconjugated 17alpha- and 17beta-boldenone in urine sample.
2007-03-14
The ultimate veal calf reference experiment: hormone residue analysis data obtained by gas and liquid chromatography tandem mass spectrometry.
2007-03-14
Effect of anabolics on bovine granulosa-luteal cell primary cultures.
2007
Determination of the androgenic potency of whole effluents using mosquitofish and trout bioassays.
2006-12-01
Criteria to distinguish between natural situations and illegal use of boldenone, boldenone esters and boldione in cattle 1. Metabolite profiles of boldenone, boldenone esters and boldione in cattle urine.
2006-12
Studies directed towards a mechanistic evaluation of inactivation of aromatase by the suicide substrates androsta-1,4-diene-3,17-diones and its 6-ene derivatives aromatase inactivation by the 19-substituted derivatives and their enzymic aromatization.
2006-10-25
C19-steroids as androgen receptor modulators: design, discovery, and structure-activity relationship of new steroidal androgen receptor antagonists.
2006-09-01
A very efficient bioconversion of soybean phytosterols mixtures to androstanes by mycobacteria.
2006-08
Scanning electron microscopy investigations on bis(2-ethylhexyl)phthalate treated Mycobacterium cells.
2006-08
Neoformation of boldenone and related steroids in faeces of veal calves.
2006-02
Characterization of boldione and its metabolites in human urine by liquid chromatography/electrospray ionization mass spectrometry and gas chromatography/mass spectrometry.
2006
Microbial hydroxylation of pregnenolone derivatives.
2005-11
Androstadienetrione, a boldenone-like component, detected in cattle faeces with GC-MS(n) and LC-MS(n).
2005-09
ADD, AED, alpha-boldenone and epitestosterone neo formation in calf faeces: preliminary results.
2005-08
The effect of ethambutol on mycobacterial cell wall permeability to hydrophobic compounds.
2005
Patents

Sample Use Guides

2-4 pills (400-800mg) a day.
Route of Administration: Oral
In Vitro Use Guide
Boldione inhibited Cytochrome P450 19A1 in human placental microsomes with the IC50 value of 530 nM.
Substance Class Chemical
Created
by admin
on Mon Mar 31 18:58:37 GMT 2025
Edited
by admin
on Mon Mar 31 18:58:37 GMT 2025
Record UNII
2166Q8568W
Record Status Validated (UNII)
Record Version
  • Download
Name Type Language
BOLDIONE
Common Name English
EXEMESTANE RELATED COMPOUND C CIII
USP-RS  
Preferred Name English
ANDROSTADIENEDIONE
Systematic Name English
1-DEHYDROANDROSTENEDIONE
Common Name English
ANDROSTA-1,4-DIEN-3,17-DIONE
Systematic Name English
TESTOSTERONE IMPURITY G [EP IMPURITY]
Common Name English
.DELTA.1,4-ANDROSTADIENE-3,17-DIONE
Common Name English
(+)-ANDROSTA-1,4-DIENE-3,17-DIONE
Systematic Name English
EXEMESTANE IMPURITY D [EP IMPURITY]
Common Name English
Androsta-1,4-diene-3,17-dione
Systematic Name English
J38.935H
Code English
1,4-ANDROSTADIENE-3,17-DIONE
Systematic Name English
NSC-49080
Code English
ANDROSTANE-1,4-DIENE-3,17-DIONE
Systematic Name English
EXEMESTANE RELATED COMPOUND C [USP-RS]
Common Name English
Classification Tree Code System Code
DEA NO. 4000
Created by admin on Mon Mar 31 18:58:37 GMT 2025 , Edited by admin on Mon Mar 31 18:58:37 GMT 2025
Code System Code Type Description
ECHA (EC/EINECS)
212-977-2
Created by admin on Mon Mar 31 18:58:37 GMT 2025 , Edited by admin on Mon Mar 31 18:58:37 GMT 2025
PRIMARY
EVMPD
SUB194899
Created by admin on Mon Mar 31 18:58:37 GMT 2025 , Edited by admin on Mon Mar 31 18:58:37 GMT 2025
PRIMARY
WIKIPEDIA
BOLDIONE
Created by admin on Mon Mar 31 18:58:37 GMT 2025 , Edited by admin on Mon Mar 31 18:58:37 GMT 2025
PRIMARY
RS_ITEM_NUM
1269083
Created by admin on Mon Mar 31 18:58:37 GMT 2025 , Edited by admin on Mon Mar 31 18:58:37 GMT 2025
PRIMARY
EPA CompTox
DTXSID00862463
Created by admin on Mon Mar 31 18:58:37 GMT 2025 , Edited by admin on Mon Mar 31 18:58:37 GMT 2025
PRIMARY
NSC
49080
Created by admin on Mon Mar 31 18:58:37 GMT 2025 , Edited by admin on Mon Mar 31 18:58:37 GMT 2025
PRIMARY
PUBCHEM
13472
Created by admin on Mon Mar 31 18:58:37 GMT 2025 , Edited by admin on Mon Mar 31 18:58:37 GMT 2025
PRIMARY
SMS_ID
100000181312
Created by admin on Mon Mar 31 18:58:37 GMT 2025 , Edited by admin on Mon Mar 31 18:58:37 GMT 2025
PRIMARY
MESH
C006573
Created by admin on Mon Mar 31 18:58:37 GMT 2025 , Edited by admin on Mon Mar 31 18:58:37 GMT 2025
PRIMARY
FDA UNII
2166Q8568W
Created by admin on Mon Mar 31 18:58:37 GMT 2025 , Edited by admin on Mon Mar 31 18:58:37 GMT 2025
PRIMARY
CAS
897-06-3
Created by admin on Mon Mar 31 18:58:37 GMT 2025 , Edited by admin on Mon Mar 31 18:58:37 GMT 2025
PRIMARY
CHEBI
40799
Created by admin on Mon Mar 31 18:58:37 GMT 2025 , Edited by admin on Mon Mar 31 18:58:37 GMT 2025
PRIMARY
DRUG BANK
DB07373
Created by admin on Mon Mar 31 18:58:37 GMT 2025 , Edited by admin on Mon Mar 31 18:58:37 GMT 2025
PRIMARY
Related Record Type Details
PARENT -> IMPURITY
CHROMATOGRAPHIC PURITY (HPLC/UV)
EP
PARENT -> IMPURITY
CHROMATOGRAPHIC PURITY (HPLC/UV)
USP